Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination

BACKGROUND: Myocarditis following coronavirus disease 2019 (COVID-19) mRNA vaccines (Pfizer-BioNTech and Moderna) has been increasingly reported. Incidence rates in the general population are lacking, with pericarditis rather than myocarditis diagnostic codes being used to estimate background rates....

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Yalile, Levy, Emily R, Joshi, Avni Y, Virk, Abinash, Rodriguez-Porcel, Martin, Johnson, Matthew, Roellinger, Daniel, Vanichkachorn, Greg, Charles Huskins, W, Swift, Melanie D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767838/
https://www.ncbi.nlm.nih.gov/pubmed/34734240
http://dx.doi.org/10.1093/cid/ciab926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767838/
https://www.ncbi.nlm.nih.gov/pubmed/34734240
http://dx.doi.org/10.1093/cid/ciab926

Ejemplares similares